Panel discussion


Date:April 23, 2024
Room:Marriott Hotel

Panel title

Beyond oncology: Navigating the shifting landscape of biopharma innovation trends

Panel summary

Are deal-making and investment trends revealing a shift away from “oncology as king” mentality?  Companies are accessing innovation through new modalities outside of IO and other therapeutic areas are rising in popularity. The spotlight might be shifting towards innovation in inflammation, neurology, cardiometabolic and anti-infectives.

Speaker information


James Drew, Consultant, Citeline


Enrico Magnani, Group Chief Strategy Officer, Helsinn
Simon T Russell, Co-founder & Chief Commercial Officer, Synendos Therapeutics
Patrik Frei, Founder and Chief Executive Officer, Venture Valuation

Company profile

Citeline (a Norstella Company) powers a full suite of complementary business intelligence offerings to meet the evolving needs of health science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory related-decisions and create real-world opportunities for growth.